Insider Selling: Liquidia (NASDAQ:LQDA) CAO Sells $68,283.39 in Stock

Liquidia Corporation (NASDAQ:LQDA) CAO Dana Boyle sold 1,581 shares of the business’s stock in a transaction on Monday, October 26th. The shares were sold at an average price of $43.19, for a total transaction of $68,283.39. Following the transaction, the chief accounting officer owned 164,028 shares in the company, valued at approximately $7,084,369.32. This represents a 0.95% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Dana Boyle also recently made the following trade(s):

• On Monday, October 12th, Dana Boyle sold 5,892 shares of Liquidia stock. The stock was sold at an average price of $28.48, for a total value of $167,804.16.

Liquidia Price Performance

Shares of LQDA opened at $45.06 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.12 and a current ratio of 2.31. The firm has a market cap of $4.03 billion, a PE ratio of 32.84, a PEG ratio of 0.39 and a beta of 0.61. The firm’s 50 day moving average price is $52.99 and its 200 day moving average price is $54.30. Liquidia Corporation has a twelve month low of $22.21 and a twelve month high of $93.61.

Liquidia (NASDAQ:LQDA) last posted its earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The company had revenue of $171.68 million for the quarter, compared to the consensus estimate of $168.48 million. During the same quarter last year, the business earned ($0.49) earnings per share. Liquidia’s quarterly revenue was up 1842.1% on a year-over-year basis. As a group, research analysts expect that Liquidia Corporation will post 2.05 EPS for the current fiscal year.

Hedge Funds Weigh In On Liquidia

Hedge funds have recently modified their holdings of the stock. Pinnacle Wealth Planning Services Inc. raised its stake in shares of Liquidia by 26.2% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 1,557 shares of the company’s stock valued at $47,000 after acquiring an additional 323 shares during the last quarter. Globeflex Capital L P acquired a new position in Liquidia during the 2nd quarter worth about $175,000. Nykredit A S bought a new stake in Liquidia during the 2nd quarter worth about $177,000. Sterling Capital Management LLC raised its stake in shares of Liquidia by 839.1% in the third quarter. Sterling Capital Management LLC now owns 2,329 shares of the company’s stock worth $70,000 after acquiring an additional 2,081 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its holdings in shares of Liquidia by 13.8% in the third quarter. Nisa Investment Advisors LLC now owns 2,634 shares of the company’s stock valued at $80,000 after purchasing an additional 320 shares in the last quarter. 64.54% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have issued reports on LQDA shares. Wall Street Zen cut shares of Liquidia from a “buy” rating to a “hold” rating in a report on Saturday, October 3rd. HC Wainwright increased their price objective on Liquidia from $58.00 to $65.00 and gave the company a “buy” rating in a research report on Thursday, October 15th. Piper Sandler set a $129.00 target price on shares of Liquidia in a research note on Friday, July 24th. Needham & Company LLC reduced their price target on shares of Liquidia from $72.00 to $58.00 and set a “buy” rating for the company in a report on Wednesday, October 14th. Finally, Bank of America upped their price objective on shares of Liquidia from $79.00 to $92.00 and gave the company a “neutral” rating in a research report on Thursday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $72.85.

About Liquidia

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with pulmonary hypertension and other serious cardiopulmonary diseases. The company is headquartered in Research Triangle Park, North Carolina, and uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition for inhaled and injectable medicines.

Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder formulation of treprostinil delivered through a proprietary inhaler.